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Highlights 
 
 Meconium is a fetal matrix which integrates a large exposure window to xenobiotics 
 Analysis of 28 target compounds with a large range of polarity 
 Comparison of six columns for analytical method development by LC/MS/MS in meconium 
 Optimization of HILIC conditions for polar compounds in meconium analysis 
Abstract 
 
Meconium is the first fecal excretion of newborns. This complex accumulative matrix allows 
assessing the exposure of the fetus to xenobiotics during the last six months of pregnancy. To 
determine the eventual effect of fetal exposure to micropolluants in this matrix, robust and 
sensitive analytical methods must be developed. This article describes the method 
development of liquid chromatography methods coupled to triple quadrupole mass 
spectrometry for relevant pollutants. The 28 selected target compounds had different physico 
chemical properties from very polar (glyphosate) to non-polar molecules (pyrethroids). Tests 
were performed with six different columns: reversed phase, ion exchange and HILIC. As a 
unique method could not be determined for the simultaneous analysis of all compounds, three 
columns were selected and suitable chromatographic methods were optimized. Similar results 
were noticed for the separation of the target compounds dissolved in either meconium extract 
or solvent for reversed phase and ion exchange columns. However, for HILIC, the matrix had 
a significant influence on the peak shape and robustness of the method. Finally, the analytical 
methods were applied to “real” meconium samples. 
 
Keywords: reversed phase; ion exchange; HILIC; LC/MS/MS; meconium; micropollutants 
Introduction 
 
Like the general population, pregnant women are commonly exposed to many environmental 
pollutants (pesticides, solvents…) which have been determined harmful to humans due to 
their carcinogenic properties and/or their effects on reproduction. To determine the exposure 
to micropollutants of women during pregnancy, the PELAGIE project (Perturbateurs 
Endocriniens: Étude Longitudinale sur les Anomalies de la Grossesse, l’Infertilité et 
l’Enfance), wherein maternal urine and cord blood samples were analyzed, was carried out in 
Brittany, France [1]. The results of this study identified some important compounds of 
interest, such as organophosphorus pesticides and dialkylphosphates (metabolites of 
organophosphorus) [2]. The constant exposure of pregnant women to these compounds could 
affect the development of the fetus and especially induce the production of congenital 
malformations. To determine if an association exists between congenital malformations and 
fetal exposure to organic pollutants, a new project, the PENEW project (Pregnancy 
Environment and NEWborn malformations), has recently been launched by the Registry of 
congenital malformations in Brittany, France. This project includes the study of compounds 
quantified in the PELAGIE project (organophosphorus pesticides) and other relevant 
molecules widely used in Brittany and suspected to be toxic for the fetus such as other 
pesticides (triazoles, pyrethroids, glyphosate…) and VOCs; with some associated metabolites. 
To evaluate direct fetal exposure to xenobiotics throughout pregnancy, fetal matrix was 
considered. Commonly used fetal matrices, such as cord blood, urine and newborn blood, 
only reflect the last days of exposure. Therefore, the meconium matrix was selected to 
represent a larger exposure window. Meconium is the first stool of a newborn. It starts 
forming during the 12th-13th week of gestation in intestinal compartments and accumulates 
until birth [3,4,5]. It is a very complex matrix [6] composed of water (~70%) and lipophilic 
compounds (~30%): lipids, proteins, bile acids, enzymes, lanugo… Usually, it is expelled by 
the newborn within 24 hours after birth. The collection of meconium is non-intrusive for the 
newborn and simple, unlike some other fetal matrices (urine, blood). 
Meconium was already used to quantify fetal exposure to drugs and metabolites [7,8], alcohol 
metabolites [9,10] or pesticides [11,12] with the analysis performed by liquid chromatography 
coupled with tandem mass spectrometry LC/MS/MS. Usually these analytical methods were 
focused only on restricted classes of compounds and eventually their metabolites [8,9,13]. To 
determine a possible link with malformations, the target compounds of the PENEW project 
regrouped a large variety of pollutants within several families of pesticides, their metabolites, 
VOCs [14] and metabolites. Compared to a previous study carried out by our group where the 
analysis of certain micropollutants was performed on a C18 column [12], the current list of 
compounds included additional pesticides (epoxiconazole, tebuconazole, 2,4-D…) and also, 
notably, substances with stronger polarity (glyphosate) or different polar functional groups 
(acid compounds with the metabolites of VOCs).  As the considered molecules encompassed 
a much larger variety in physicochemical properties, ranging from very polar to non-polar, the 
previously developed method was inadequate for the extended list of substances.  
Analytical method development was therefore performed for the 28 substances in meconium. 
Extraction methods for these compounds have been investigated and described elsewhere 
[15]. The aim of the method development by LC/MS/MS was to obtain one or several 
methods suited for all target substances with acceptable retention times (not eluted in the void 
volume), peak shapes and sensitivity with the fewest constraints. Analysis time was also 
considered due to the large number of samples to be analyzed (around 235 meconium 
samples). Tests on several columns with different properties, buffer optimization and matrix 
effects are described in this article. Chromatographic tests with meconium matrix were carried 
out after the sample preparation optimized in this matrix [15]. The final analytical method was 
applied to real PENEW “cases”. 
 
Experimental 
 
Chemicals and materials 
 
O-cresol (o-C, purity: 99.9%), hippuric acid (HA, 98.0%), 2-methylhippuric acid (2-MHA, 
98.0%), 3-methylhippuric acid (3-MHA, 98.0%), 4-methylhippuric acid (4-MHA, 98.0%), 
phenylglyoxylic acid (PGA, 98.0%), S-phenylmercapturic acid (S-PMA, 99.0%), 
diethylthiophosphate (DETP, 98.0%), 2,4-dichlorophenoxyacetic acid (2,4-D, ≥ 98.0%), 
diazinon (purity: 98.3%), cypermethrin (98.5%), cyfluthrin (99.8%), deltamethrin (99.7%), 
clopyralid (99.3%), glyphosate (99.2%), tebuconazole (99.5%), propoxur (99.8%), dichlorvos 
(99.9%) and benzoic acid-d5 (BA-d5, 99.0%) were purchased from Sigma-Aldrich Chemie 
GmbH (Steinheim, Germany). S-benzylmercapturic acid (S-BMA, purity: 98.0%) was 
obtained from Sigma-Aldrich (Milwaukee, WI, USA). Chlorpyrifos (purity: 99.9%), 
malathion (97.2%), epoxiconazole (99.2%) were purchased from Riedel-de Haën (Seelze, 
Germany). Dimethylthiophosphate (DMTP, 99.2%), dimethyldithiophosphate (DMDTP, 
99.4%), 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid (DCCA, purity ≥ 
95.0%, at 100 µg.mL-1 in acetonitrile), diethylthiophosphate-d10 (DETP-d10, purity: 98.0%, 
at 100 µg.mL-1 in methanol) were obtained from Cambridge Isotope Laboratories Inc. 
(Andover, MA, USA). Dimethylphosphate (DMP, 98.0%) was obtained from Acros Organics 
(Geel, Belgium). Permethrin (99.8%) was purchased from Ultra Scientific (Rhode Island, 
USA). Mandelic acid (MA, 99.0%) was obtained from ChromaDex (Irvine, CA, USA). 
Diethylphosphate (DEP, 99.5%) was obtained from Chem Service Inc. (West Chester, PA, 
USA). 3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (Br2CA, 99.0%, at 
10 µg.mL-1 in methanol), diazinon-d10 (96.5%, at 100 µg.mL-1 in acetonitrile), propoxur-d3 
(99.5%, at 100 µg.mL-1 in acetonitrile), dichlorvos-d6 (96.0%, at 100 µg.mL-1 in 
cyclohexane), trans-cypermethrin-d6 (98.5%, at 100 µg.mL-1 in acetonitrile), chlorpyrifos-
d10 (98.0%, at 100 µg.mL-1 in acetonitrile), tebuconazole-d6 (95.0%, at 100 µg.mL-1 in 
acetonitrile), 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid-d6 (DCCA-d6, 
96.0%, at 100 µg.mL-1 in acetonitrile), 2,4-dichlorophenoxyacetic acid-d3 (2,4-D-d3, 97.0%, 
at 100 µg.mL-1 in acetonitrile) were purchased from Dr. Ehrenstorfer (Augsburg, Germany). 
Hippuric acid-d5 (HA-d5, 98.0%) was obtained from Toronto Research Chemicals Inc. 
(North York, Canada). 
Sodium acetate (NaOAc), ammonium hydroxide solution (NH4OH) (99.9%), and LC-MS 
grade methanol (MeOH) and acetonitrile (ACN) (≥ 99.9%) were obtained from Sigma-
Aldrich (Steinheim, Germany). Ammonium acetate (> 98%) was obtained by Merck 
(Darmstadt, Germany). Ultrapure water was supplied by a Mili-Q water purifier system from 
Millipore (Bedford, MA, USA). Acetic acid (100%) and sodium sulfate anhydrous (NaSO4) 
were purchased from VWR BDH Prolabo (Leuven, Belgium). 
 
Meconium 
 
For method development, a pool of meconium was obtained from meconium samples 
collected from autopsied fetus and autopsied newborns by the anatomical pathology service of 
the University Hospital of Rennes, France. When tested, some of these meconium did not 
contain any of the analytes. These “blank” meconium were pooled to form a representative 
pool of “blank” meconium for use in all subsequent experiments. Meconium samples were 
kept at - 80°C until analysis to prevent bacteriological developments. 
 Sample preparation 
 
The extraction procedure of meconium specimens for quantification using the LC/MS/MS 
was the same as described previously [15]. 
Briefly, 1 g of meconium sample was diluted with 8 mL of water. Ammonium hydroxide and 
the internal standards were added to 6 mL of the diluted sample. After vortex and 
centrifugation, 4 mL of supernatant were filtered. To the remaining meconium phase, ACN, 
ammonium sulfate and ammonium acetate were added. The supernatant was evaporated at 
500 µL. The two supernatants were pooled together before performing purification steps with 
a Bond Elut SAX cartridge (Agilent). The elutions of loading and washing steps of the Bond 
Elut SAX cartridge were purified with a Strata-X cartridge (Phenomenex). The elutions of the 
two SPE cartridges were pooled together before LC/MS/MS analysis. 
Pyrethroids are not soluble in water. To avoid precipitation of pyrethroids or glyphosate in a 
unique solution, standard solutions were prepared in 100 µL of water/ACN (50/50 v/v) for 
analysis with Ascentis Express RP-Amide and Acclaim Trinity P1 columns (one injection of 
10 µL for each column). For analysis with LUNA HILIC column, the 80 µL of remaining 
solvent (mixture of ACN and water) in vial were evaporated to dryness and reconstituted in 
80 µL of ACN. 
 
Liquid chromatography columns tests 
 
The meconium and calibration samples were analyzed on an Acquity UPLC H-Class from 
Waters (Milford, MA, USA). Chromatographic development was accomplished with six 
columns: Ascentis Express C18, 150 × 2.1 mm, 2.7 µm from Supelco (Bellefonte, USA); 
Ascentis Express RP-Amide, 150 × 2.1 mm, 2.7 µm from Supelco (Bellefonte, USA); 
Ascentis Express Phenyl-Hexyl, 150 × 2.1 mm, 2.7 µm from Supelco (Bellefonte, USA); 
Acclaim Trinity P1, 150 × 2.1 mm, 3 µm from Thermo Fisher Scientific (Asheville, NC, 
USA); Ascentis Express HILIC, 150 × 2.1 mm, 2.7 µm from Supelco (Bellefonte, USA); and 
LUNA HILIC, 150 × 2.0 mm, 3 µm from Phenomenex (Torrance, CA, USA).  
 
Optimized conditions for liquid chromatography 
 
Chromatographic separation was carried out on three columns equipped with a pre-column: 
Acclaim Trinity P1, Ascentis Express RP-Amide and Luna HILIC. The mobile phase 
consisted of ammonium acetate buffer 20 mM set at pH 3 with acetic acid (solvent A) and 
acetonitrile (solvent B). The gradient program for the Ascentis Express RP-Amide column 
was as followed: isocratic hold at 100% A for 2 min; from 100% A to 100% B in 8 min; hold 
at 100% B for 2 min (total gradient time: 12 min). The gradient program for the Acclaim 
Trinity P1 column was:  isocratic hold at 95% A for 2 min; from 95% A to 50% A in 3 min 
(total gradient time: 5 min). For the Luna HILIC column, a linear gradient from 100% B to 
60% B in 5 min was used. The aqueous mobile phase was ammonium acetate buffered with 
acetic acid (mobile phase A) and acetonitrile as solvent (mobile phase B). The columns were 
constantly heated at 30°C for a better repeatability and the injection volume was set to 10 µL. 
All the runs were performed at a flow rate of 400 µL min-1. 
Using the current instrumentation, among different usage, the so called purge solvent is used 
to push the sample along the injection pathway. Therefore, the purge solvent comes into 
contact with the sample so its composition must be set close to the sample solvent 
composition. For Ascentis Express RP-Amide and Acclaim Trinity P1, the purge solvent 
consisted of water/MeOH (90/10: v/v). For the experiments performed with the LUNA HILIC 
column, the purge solvent consisted of ACN alone.  
 
Mass spectrometry 
 
The LC was coupled to a triple quadrupole mass spectrometer Acquity UPLC TQ Detector 
from Waters (Milford, MA, USA) in ESI positive and negative mode. The electrospray source 
was used at 150°C with a desolvation temperature of 400°C and a capillary voltage of 
± 3.30 kV (Tables 1 and 2). Nitrogen was used as nebulizer gas with desolvation gas flow set 
at 800 L Hr-1, cone gas flow set at 50 L Hr-1 and argon as collision gas with flow rate set at 
0.17 mL min-1. 
For MS detection, whenever possible, two ions were used for each compound in Multiple 
Reaction Monitoring (MRM) mode: one target ion for quantification and one qualifier ion for 
confirmation (Tables 1 and 2). MassLynx software (Waters) was used for data acquisition and 
processing. 
 
Results and discussion 
 
The analysis of meconium is challenging because of the complex nature of this matrix. Each 
step of the analytical protocol has to be thoroughly optimized in order to reduce matrix 
effects. The determination of suitable chromatographic parameters is particularly critical to 
ensure a reliable and sensitive analysis. Separation from the matrix will ensure that 
interferences are reduced on peak shapes and sensitivity. Many components extracted from 
the matrix elute in the void volume so all target components must have a retention time of at 
least 2 times the void volume of the column. Moreover, even if detection by mass 
spectrometry is selective, two transitions are used to confirm the identity of the detected 
components by MS/MS, this significantly decreases the possibility of obtaining a false 
positive by wrongly identifying a component. For compounds with adequate retention time, 
the selectivity provided by mass spectrometry implies that compounds that co-elute can still 
be identified and quantified. However, the complexity of the matrix, despite intensive sample 
preparation, still has a large effect on the spectrometric response as demonstrated in [15]. 
Therefore, the developed method must represent the best compromise between the time of 
analysis and the efficiency of the separation.  
For this particular study, the chromatographic analysis was also a significant part of this 
method development because of the large polarity range of the target molecules: from very 
polar (log Kow = - 4.0 for glyphosate) to non-polar (log Kow = 5.7 for deltamethrin). The aim 
of this optimization was therefore to develop (an) easy and fast chromatographic method(s) 
for all target compounds. 
The selection of columns was based on two criteria: adequate retention of the molecules on 
the column and good peak shape to maximize the sensitivity of the analysis. 
 
Evaluation of the chromatographic separation with one column 
 
To reduce the total analysis time, quantification of all target compounds using only one 
column would represent the ideal case. Considering the nature of the investigated compounds, 
from polar to non-polar, this column should display different types of interaction suitable for 
these molecules. Mixed-mode columns allow retaining different compounds with several 
interactions. Acclaim Trinity P1 is a trimodal column which allows different phase/molecule 
interactions: reversed-phase and ion exchange. These interaction modes depend on the 
ionization of the molecules. For chromatographic analysis, this state mainly depends on the 
pH of the buffer. Tests with different pH were therefore performed. These experiments were 
carried out with ACN and 20 mM buffer at pH 3 and 6. The flow rate was set at 400 µL min-1 
and the gradient program was: isocratic hold at 95% A for 2 min; from 95% A to 95% B in 
13 min; hold at 95% B for 2 min; then back to 95% A in 2 min and hold for 3.5 min at 95% A 
(total gradient time: 22.5 min). Most of the target compounds were separated both at acidic 
and neutral pH (fig. 1a and 1b). For analysis at pH 3 (fig. 1a), only two molecules could not 
be eluted: PGA and clopyralid while DETP was detected at 18.5 min. At pH 6 (fig. 1b), 
glyphosate and DMP were not or very little retained, and 2,4-D eluted at 18.9 min. For the 
dialkylphosphates (DAPs), glyphosate, PGA, clopyralid and 2,4-D, the principal mechanism 
of retention was ion exchange. These compounds were more retained at pH 3, except for 2,4-
D which was more retained at pH 6. Indeed, at pH 3, this molecule was partially ionized 
whereas it is completely ionized at high pH. As shown in fig. 1a and 1b, several compounds 
such as the organophosphorus pesticides, propoxur, triazoles and pyrethroids were retained 
through a reversed-phase mechanism as their retention was not influenced by the buffer pH. 
Overall, even if most of the target compounds eluted with a retention time ≥ 2 times the void 
volume, some were not retained and/or presented poor peak shapes at each pH. This method 
could therefore be relevant for studies where high concentrations are expected but for this 
particular work aiming at traces analysis, this constituted a limitation. Therefore the present 
analytical method was not selected for the quantification of all target compounds in 
meconium. Another method using multiple columns was rather envisaged to obtain good peak 
shapes and retention times for all studied compounds. 
 
Evaluation of the separation with multiple columns  
 
Reversed-phase optimization 
 As an analysis on only one column was not possible, tests with reversed phase columns were 
carried out to analyze most of the target compounds. Literature showed that this type of 
column was suitable for pesticide analysis in different matrices, such as water [16-18] and 
biological matrices like urine [19] or meconium [12]. In a previous work by our group [12], a 
C18 column was used to analyze pesticides and their metabolites in meconium. However, this 
column was not suitable for this work due to the larger range of polarity and functional groups 
for the considered compounds. Three reversed-phase columns with different functional groups 
were therefore tested: Ascentis Express C18, Ascentis Express RP-Amide, and Ascentis 
Express Phenyl-Hexyl. Ascentis Express C18 was chosen as a reference C18 reversed phase. 
Ascentis Express RP-Amide was tested because it can improve the peak shape of some 
molecules compared to Ascentis Express C18. Finally, most of the target molecules had a 
phenyl group which could interact with a stationary phase containing a phenyl group such as 
Ascentis Express Phenyl-Hexyl. 
For the tests of the 3 reversed phase columns, the same experimental conditions were used 
(gradient, mobile phase with buffer composed of ammonium acetate and acetic acid/ACN). 
The flow rate was set at 400 µL min-1 and gradient program was isocratic hold at 95% A for 
2 min; from 95% A to 95% B in 13 min; hold at 95% B for 2 min; then back to 95% A in 2 
min and hold for 3.5 min at 95% A (total gradient time: 22.5 min).  
The mobile phase pH is an important parameter for column selectivity particularly in this 
study given the high number of substances with ionizable groups. Therefore, buffers were 
tested at pH 3 and pH 6. Overall, compared to the results obtained with the mixed mode 
Acclaim Trinity P1 column, better peak shapes were obtained for most compounds using the 
reversed phase columns. 
While most compounds, such as diazinon, remained unaffected by pH changes, some 
molecules with particular functional groups such as mandelic acid or S-PMA presented 
distorted peaks depending on the pH or the column (fig. S1).  
At pH 6, acidic compounds such as mandelic acid or S-PMA are ionized and therefore elute at 
or close to the void volume. Moreover, peak shapes were very broad on all columns for S-
PMA at pH 6. For this type of compound, the same behavior was noticed on the Acquity BEH 
C18 used at this pH in our previous work (data not shown) [12]. At pH 3, mandelic acid and 
S-PMA are mainly neutral. Therefore, interactions with these stationary phases are mainly 
governed by hydrophobic interactions. 
At pH 3, broad peak shapes were observed for mandelic acid with Ascentis Express C18 and 
for Ascentis Express Phenyl-Hexyl columns but the Ascentis RP-Amide provided an 
acceptable result in term of peak shapes and retention times. At this pH, the Ascentis RP-
Amide appeared more suitable for the analysis of polar compounds. 
The peak shape and the retention of diazinon were not influenced by pH because this 
compound is in neutral form at pH 3 or 6. 
Finally, with the 3 tested columns, glyphosate and DAPs (except DMDTP) were also not or 
poorly retained because of their high polarities. Therefore, the Ascentis Express RP-Amide 
column at pH 3 was selected (fig. 2) for the analysis of all compounds apart glyphosate and 
DAPs (except DMDTP). 
 
HILIC optimization 
 
Several published methods use C18 columns to analyze dialkylphosphates (DAPs) [20-22]. In 
our previous work [12], a C18 column was also used to analyze DAPs along with other 
pesticides. But as demonstrated, the buffer conditions which were used here (pH 6) were not 
suitable for the analysis of the acidic compounds in this study. Moreover, considering the 
sample preparation was changed to account for the wider range of polarities of the 
investigated compounds in this study, interferences during the spectrometric detection were 
noticed with the analysis of the very polar DAPs under these conditions.  
Therefore, Hydrophilic Interaction Chromatography (HILIC) was evaluated. As an alternative 
to normal phase, this interaction mode is used for the liquid chromatographic separation of 
polar and hydrophilic molecules that are not retained using reversed-phase liquid 
chromatography. The separation is based principally on electrostatic interactions (ionized 
analytes, ions contained in buffer (salt) and deprotonated silanols of stationary phase) and 
hydrophilic partitioning (between the buffer layer at the surface of the stationary phase and 
the organic layer) [23,24]. Many HILIC stationary phases are available: bare silica, polar 
functionalities bonded to silica or polymer coating bonded to silica.  
This type of column is very sensitive to chromatographic conditions and to matrix effects. 
Optimization of the separation by HILIC was carried out by testing 2 different types of HILIC 
columns and by evaluating the nature and concentration of salt and the buffer pH. 
The two HILIC columns tested were an Ascentis Express HILIC and a LUNA HILIC. The 
first column contains a fused core silica phase and the second has a cross-linked diol on the 
silica phase. 
Tests with glyphosate demonstrated that this molecule was too strongly retained on the HILIC 
column and could hence not be eluted. Therefore, the HILIC method optimization was 
focused on the analysis of DAPs. 
A mixture of DAPs prepared in ACN was analyzed with the Ascentis Express HILIC column 
with a gradient starting at 100% ACN. Indeed, when experiments with different gradients 
starting with low percentage of water (95% or 98%) were carried out, DETP was eluted in the 
void volume of the column. With the gradient starting at 100% ACN, all the injections 
performed with the pool of meconium were reproducible in term of retention times. 
An experiment was performed to check the influence of the purge solvent. The purge solvent 
was a mixture of water/MeOH (90/10) as used for the analysis with the reversed-phase and 
Acclaim Trinity P1 columns. Under these conditions, two DAPs, DETP and DMTP, eluted in 
the void volume of the column. Therefore, the rest of the method optimization was carried out 
with a mixture of standards prepared in ACN and with a purge solvent consisting of ACN 
only.  
 
Influence of buffer 
 
Addition of salt (compatible with MS detection) to the mobile phase allows improving 
retention time, selectivity and peak shapes in HILIC [25,26]. Indeed, charges induced by the 
salt create electrostatic interactions with ionized compounds [27]. To determine the influence 
of this parameter on the two HILIC columns, two buffers were tested: 20 mM of ammonium 
acetate/acetic acid at pH 3 and 20 mM of ammonium formate/formic acid at pH 3. At the 
same pH, molecule retention time and peak shape depend on buffer type [26]. Better peak 
shapes and an increase in retention time were obtained for DEP and DMP for the Ascentis 
Express HILIC column with ammonium acetate as observed in other studies (fig. 3a and 3b).  
For the LUNA HILIC column, better peak shapes were also observed for DEP and DMP with 
this buffer (fig. 3b) while for DETP and DMTP, the two buffers provided poor retention 
(fig. 3b and 3d). With these results, subsequent tests were carried out in ammonium acetate 
solution. 
The effect of the salt concentration was investigated using 10, 20, 50, 80 and 100 mM of salt 
in aqueous solution. On the LUNA HILIC column (fig. S2a), a slight increase of retention 
was observed for DETP and DMTP when the salt concentration in the buffer was increased. 
On the Ascentis Express HILIC column (fig. S2b), the retention times of DETP and DMTP 
decreased slightly with increasing ammonium acetate level. A decrease in DMP retention was 
observed from 10 to 50 mM of salt which then stabilized at higher concentrations. The same 
phenomenon (decrease of retention time) was noticed for DETP but in the range from 10 to 
20 mM. An ammonium acetate buffer concentration of 20 mM was therefore selected. 
 
Influence of pH 
 
Four pH-values were tested: 3, 4, 5 and 6.5. The effect of mobile phase pH on the LUNA 
HILIC column is presented in fig. 4a. With 20 mM of ammonium acetate (full markers), 
retention times of DETP (pKa ؄ 2.7) and DMTP (pKa ؄ 2.9) slightly increase from pH 3 to 
pH 4 but decrease for higher pH-values to elute close to the void volume at pH 6.5. This trend 
can be correlated with the pKa of these 2 compounds which are mainly in neutral form up to 
pH 4 and are then ionized for higher pHs. For DMP and DEP, a decrease was observed from 
pH 3 to pH 6.5. Indeed, DMP (pKa ؄ 2.0) and DEP (pKa ؄ 1.9) are charged negatively at 
pH 3. From pH 4, the retention time of all compounds decreased because competition 
phenomena increased between ionized target molecules and increasing levels of acetate ions 
to create electrostatic interactions with the cross-linked diol phase. Overall, the same trend 
was observed with the formate buffer (empty symbols), retention times were stable from pH 3 
to pH 5 and then decreased significantly.  
On the Ascentis Express HILIC column (fig. 4b) and using ammonium acetate buffer (full 
symbols), no effect on the retention times of DMP and DEP was noticed when the pH varied 
between pH 3 and pH 5. At pH values higher than 5, the ionized DEP and DMP are in 
competition with acetate ions (more electronegative) for electrostatic interactions accounting 
for the decrease in retention time. For DETP/DMTP, retention times are stable over the entire 
pH range. As shown by the empty symbols, the retention times of all compounds were 
independent of the pH-value when using formate buffer. The same trend as observed with the 
acetate buffer was again seen for DETP and DMTP. However, for DMP and DEP, no 
decrease in retention was observed. The electronegativity of the formate ions might be less 
strong than those of DEP and DMP, so their electrostatics interactions are not modified with a 
pH change. 
At pH 6.5, several compounds were poorly retained so this pH was not chosen. In general, 
variations of retention times between pH 3, 4 and 5 were minimal. Therefore, pH 3 was 
selected. With this choice, the buffer was the same as for the analysis with Ascentis Express 
RP-Amide. 
The gradient was optimized to improve MS sensitivity, peak shapes and retention times:  
100% of ACN to 60% at 5 min, then 100% of ACN at 7 min, hold 3 min; with 20 mM of 
ammonium acetate buffer at pH 3 with acetic acid used. In these conditions, all compounds 
were retained on the Ascentis Express HILIC column (fig. 3b) but peak shapes of DMTP and 
DETP remained unacceptable on the LUNA HILIC column (fig. 3a).  
 
Choice of HILIC column for meconium analysis 
 
HILIC columns are very sensitive to matrix effects. To select a suitable column, a meconium 
extract containing DAPs was analyzed by LC/MS/MS. As shown in fig. 5, the chromatogram 
obtained for the meconium extract was very different from the chromatogram obtained in 
solvent (fig. 3). DMP was slightly affected by a matrix effect with good peak shape but the 
retention time shifted by 0.2 min. The retention time of DEP was not modified but diffusion 
effects were observed as for DETP and DMTP resulting in severe band broadening. 
Interactions between these two last compounds and meconium extract were very important. 
Parts of the meconium matrix which were not removed during the purification process created 
interferences and interacted with the stationary phase and/or the target compounds. These 
interactions prevented the DAPs to link strongly with the bare silica phase.  
Under identical analytical conditions, the same meconium extract was analyzed with the 
LUNA HILIC column (fig. 5a). In contrast to the Ascentis Express HILIC column (fig. 5b), 
the peak shapes were improved for DEP, DMTP and DETP compared to the analysis in 
solvent (fig. 3b and 3d). It can be assumed that the meconium matrix had a positive effect by 
neutralizing the groups of the stationary phase responsible for the distorted peak shapes 
observed in solvent. This column was therefore selected for the analysis of the target 
molecules in the meconium samples. 
To evaluate the importance of matrix effects further, a comparison with the chromatographic 
method proposed in this article and the one published by Odetokun et al. [28] in human urine 
was performed with the LUNA HILIC column. The chromatographic method of Odetokun et 
al. consisted of 93% of ACN and 7% of 100 mM ammonium acetate in isocratic mode with a 
flow rate at 400 µL min-1. In solvent, the best peak shapes were obtained for DETP and 
DMTP with the method of Odetokun et al. (fig. 6a) but for DEP and DMP, our optimized 
method provided better results. For the meconium extract (fig. 6b), our method again lead to 
the best peak shapes for all DAPs. 
This experiment demonstrates the particular nature and effect of the meconium matrix on the 
chromatographic HILIC conditions. Therefore, when dealing with complex matrix such as 
meconium, all final optimizations should preferentially be performed in the studied matrix. 
 
Acclaim Trinity P1 optimization for glyphosate 
 
Usually, glyphosate is derivatized for chromatographical analysis on reversed-phase columns. 
For underivatized glyphosate, columns with weak anion-exchange properties can be used to 
obtain sufficient retention and selectivity [29,30]. Indeed, in our tests, glyphosate was not 
retained on the reversed-phase columns and could not be eluted with the HILIC columns. 
Further tests were therefore performed with the Acclaim Trinity P1 to benefit from the ion 
exchange interactions as seen in § 2.1. Retention with the Acclaim Trinity P1 depends very 
much on the buffer composition: salt concentration and pH. These two parameters were 
evaluated for glyphosate analysis. 
 
Influence of pH 
 
Several articles on underivatizated glyphosate analysis with LC using an anion-exchange 
column with acidic buffer have been published [29,31]. To verify these methods, two buffer 
pHs were tested with 20 mM of ammonium acetate: at pH 3 with acetic acid addition and 
pH 6 (pH limit conditions indicated by the manufacturer). The flow rate was set at 
400 µL min-1 and ACN was used as solvent. The gradient program was isocratic hold at 95% 
A for 2 min; from 95% A to 95% B in 13 min; hold at 95% B for 2 min; then back to 95% A 
in 2 min and hold for 3.5 min at 95% A (total gradient time: 22.5 min).  At pH 6, glyphosate 
eluted in the void volume of the column. Indeed, at this pH, anion exchange interactions are 
weak and hydrophobic interactions were insufficient to retain this compound as observed with 
reversed phase columns. Finally, a buffer set at pH 3 was selected since glyphosate was 
retained under these conditions. 
 
Variation of salt concentration 
 
The separation optimization on a trimodal column is influenced mainly by the effect of the 
mobile phase ionic strength (concentration and pH of buffer) [32]. The influence of the buffer 
salt concentration on the Acclaim Trinity P1 column was tested for different concentrations of 
ammonium acetate (5, 10, 15, 20 and 30 mM) at pH 3. The chromatographic conditions were 
the same as described in the previous paragraph. As shown in fig. S3, glyphosate was 
sensitive to the variation of ammonium acetate concentration. Indeed, the retention time of 
this molecule decreased with increasing buffer concentration. With 5 mM buffer, it was not 
eluted because the mobile phase had no sufficient ionic strength: interactions with glyphosate 
and the stationary phase were stronger than the glyphosate/mobile phase interactions. From 
10 mM of ammonium acetate on retention increased slightly (6.42 min for 10 mM; 6.07 min 
for 15 mM and 4.62 min for 30 mM) and an improvement of the peak shape was observed 
with a reduction of peak tailing. A buffer containing 20 mM of ammonium acetate was 
therefore selected for the analysis of glyphosate on the Acclaim Trinity P1 column since it 
provided an acceptable result and for convenience of the overall analysis as this mobile phase 
was also used for the two other chromatographic methods in this work (reversed phase and 
HILIC).  
 
Application to real samples 
 
The full analytical protocol including sample preparation was validated and is described 
elsewhere [15]. It was  applied overall to 235 meconium samples as part of the PENEW 
project. The meconium matrix is specific for each newborn; therefore the composition of the 
matrix varies for each analysis. Indeed, for the analysis of the 235 meconium samples with the 
LUNA HILIC column, an average retention time of 2.46 min was observed for the internal 
standard DETP-d10. The minimal retention time for this compound was 1.69 min and the 
maximum 3.35 min. This deviation was not present when the matrix matched calibration was 
carried out with the same pool of meconium and with the quality controls inserted within the 
sequence of samples analysis. This phenomenon was noticed only with the analysis performed 
with the HILIC column demonstrating this column is particularly sensitive to matrix effects. 
Therefore, the use of a specific internal standard is required to take into account the variation 
of retention times produced by the difference in composition of the meconium samples.  
 
Conclusion 
 
Meconium is a complex accumulative matrix that can reflect fetal exposure to xenobiotics. To 
quantify 28 target compounds presenting a wide range of physico chemical properties in this 
matrix by LC/MS/MS, a test using only one column (of the most widely used type) did not 
provide satisfying results. Therefore an approach with three different complementary 
chromatographic methods was developed to obtain an orthogonal system suitable for all target 
compounds: one with a reversed-phase column for most of the target molecules (semi-polar to 
non-polar compounds), one with a HILIC column for polar metabolites (dialkylphosphates) 
and one with an ion-exchange column for a very polar pesticide (glyphosate). Analysis of 
meconium extracts was particularly critical using HILIC which demonstrated significant 
variation when analytical conditions/ matrix were changed. This analytical approach was 
successfully tested on 235 meconium samples. 
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Fig. 1 Acclaim Trinity P1 chromatogram in solvent : a) at pH3 and b) at pH6: 1, PGA; 2, 
clopyralid; 3, MA; 4, o-cresol; 5, HA; 6, MHA; 7, S-PMA; 8, S-BMA; 9, dichlorvos; 10, 
propoxur; 11, 2,4-D; 12, DCCA; 13, epoxiconazole; 14, malathion; 15, DMDTP; 16, Br2CA; 
17, tebuconazole; 18, diazinon; 19, cyfluthrine; 20, chlorpyrifos; 21, cypermethrin; 22, 
deltamethrin; 23, permethrin; 24, glyphosate; 25, DMP; 26, DEP; 27, DMTP; 28, DETP 
Fig. 2 Analysis of meconium spiked with target compounds by Ascentis Express RP-Amide 
Fig. 3 Chromatogram of DAPs in solvent analyzed with 20 mM of ammonium acetate at pH 3 
by a) Ascentis Express HILIC and by b) LUNA HILIC; and with 20 mM of ammonium 
formate at pH 3 by c) Ascentis Express HILIC and by d) LUNA HILIC 
Fig. 4 The effect of buffer pH on a) HILIC LUNA and b) Ascentis Express HILIC columns 
on the retention of DAPs. With ammonium acetate: ( ) DEP, ( ) DMP, ( ) DETP and ( ) 
DMTP; and with ammonium formate: ( ) DEP, ( ) DMP, ( ) DETP and ( ) DMTP 
Fig. 5 Chromatogram of spiked meconium analyzed with 20 mM of buffer at pH 3, with a) 
LUNA HILIC, b) Ascentis Express HILIC 
Fig. 6 Chromatogram of DAPs with two chromatographic methods: Odetokun [28] conditions 
(dotted lines) and optimized conditions (solid lines) in solvent (a) and in spiked meconium (b) 
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Fig. 3 Chromatogram of DAPs in solvent analyzed with 20 mM of ammonium acetate at pH 3 
by a) Ascentis Express HILIC and by b) LUNA HILIC; and with 20 mM of ammonium 
formate at pH 3 by c) Ascentis Express HILIC and by d) LUNA HILIC 
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Fig. 4 The effect of buffer pH on a) HILIC LUNA and b) Ascentis Express HILIC columns 
on the retention of DAPs. With ammonium acetate: ( ) DEP, ( ) DMP, ( ) DETP and ( ) 
DMTP; and with ammonium formate: ( ) DEP, ( ) DMP, ( ) DETP and ( ) DMTP 
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Fig. 5 Chromatogram of spiked meconium analyzed with 20 mM of buffer at pH 3, with a) 
LUNA HILIC, b) Ascentis Express HILIC 
b) a) 
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Fig. 6 Chromatogram of DAPs with two chromatographic methods: Odetokun [28] conditions 
(dotted lines) and optimized conditions (solid lines) in solvent (a) and in spiked meconium (b) 
Table 1 Chromatographic and MS parameters for target compounds 
a) 
b) 
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Family Compound 
Chromatographic 
method 
Ionization 
mode 
Cone 
energy (V) 
Quantification 
transition 
(m/z) 
Collision 
energy (V) 
Qualification 
transition 
(m/z) 
Collision
energy (V)
 S-PMA 
Reverse phase 
ESI + 20 240 > 181 15 240 > 198 9 
 S-BMA ESI + 18 254 > 91 22 254 > 212 9 
 o-C ESI - 30 107 > 107 3   
BTEX 
metabolites 
HA ESI + 18 180 > 105 12 180 > 77 12 
 MA ESI - 25 151 > 151 3 151 > 107 9 
 PGA ESI - 25 149 > 77 10 149 > 105 8 
 o,m,p-MHA ESI + 18 194 > 119 12 194 > 194 3 
Organophosphor
us 
Dichlorvos 
Reversed phase 
ESI + 30 221 > 109 18 221 > 145 13 
Chlorpyrifos ESI + 23 352 > 200 18 352 > 125 30 
Diazinon ESI + 30 305 > 153 21 305 > 169 21 
Malathion ESI + 20 331 > 285 7 331 > 127 13 
Dialkylphosphat
es 
(metabolites of 
organophosporus
) 
DETP 
HILIC 
ESI - 20 169 > 95 14 169 > 141 8 
DEP ESI + 22 155 > 155 3 155 > 127 8 
DMP ESI + 32 127 > 95 17 127 > 109 13 
DMTP ESI - 27 141 > 126 11 141 > 95 14 
DMDTP Reversed phase ESI + 30 159 > 125 6 159 > 159 3 
Pyrethroids 
Cyfluthrin 
Reversed phase 
ESI + 25 435 > 191 9 435 > 127 27 
Cypermethrin ESI + 25 433 > 191 12 433 > 416 6 
Deltamethrin ESI + 27 506 > 281 12 506 > 253 22 
Permethrin ESI + 30 408 > 355 12 408 > 183 12 
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Pyrethroid 
metabolites 
DCCA 
Reversed phase 
ESI - 28 207 > 207 3 209 > 209 3 
Br2CA ESI + 25 299 > 299 3   
Triazoles 
Epoxiconazol
e 
Reversed phase 
ESI + 22 330 > 121 19 330 > 141 15 
Tebuconazol
e 
ESI + 30 308 > 125 34 308 > 151 21 
Carbamate Propoxur Reversed phase ESI + 16 210 > 111 14 210 > 168 8 
Phenoxy 
alkanoic acid 
2.4-D Reversed phase ESI - 26 219 > 161 12 219 > 125 28 
Picolinic acid Clopyralid Reversed phase ESI + 20 192 > 174 11 192 > 146 13 
Phosphonoglycin
e 
Glyphosate Mixed mode ESI + 25 170 > 88 12 170 > 60 12 
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Highlights 
 
 Meconium is a fetal matrix which integrates a large exposure window to xenobiotics 
 Analysis of 28 target compounds with a large range of polarity 
 Comparison of six columns for analytical method development by LC/MS/MS in meconium 
 Optimization of HILIC conditions for polar compounds in meconium analysis 
 
 
